Proteome Sciences (LON:PRM) Stock Price Down 18.5% – Time to Sell?

Proteome Sciences plc (LON:PRM) shares fell 18.5% during trading on Thursday . The stock traded as low as GBX 2.89 ($0.04) and last traded at GBX 2.89 ($0.04). 1,014,536 shares traded hands during mid-day trading, an increase of 367% from the average session volume of 217,283 shares. The stock had previously closed at GBX 3.55 ($0.05).

Proteome Sciences Stock Performance

The company has a market cap of £9.98 million, a price-to-earnings ratio of -2.45 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The stock’s 50 day moving average price is GBX 4.05 and its 200 day moving average price is GBX 3.46.

Proteome Sciences (LON:PRM) last issued its quarterly earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) EPS for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.